FFLUNet: Feature Fused Lightweight UNet for brain tumor segmentation.

Comput Biol Med

School of Medical Science and Technology, Indian Institute of Technology, Kharagpur, 721302, WB, India.

Published: August 2025


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Brain tumors, particularly glioblastoma multiforme, are considered one of the most threatening types of tumors in neuro-oncology. Segmenting brain tumors is a crucial part of medical imaging. It plays a key role in diagnosing conditions, planning treatments, and keeping track of patients' progress. This paper presents a novel lightweight deep convolutional neural network (CNN) model specifically designed for accurate and efficient brain tumor segmentation from magnetic resonance imaging (MRI) scans. Our model leverages a streamlined architecture that reduces computational complexity while maintaining high segmentation accuracy. We have introduced several novel approaches, including optimized convolutional layers that capture both local and global features with minimal parameters. A layerwise adaptive weighting feature fusion technique is implemented that enhances comprehensive feature representation. By incorporating shifted windowing, the model achieves better generalization across data variations. Dynamic weighting is introduced in skip connections that allows backpropagation to determine the ideal balance between semantic and positional features. To evaluate our approach, we conducted experiments on publicly available MRI datasets and compared our model against state-of-the-art segmentation methods. Our lightweight model has an efficient architecture with 1.45 million parameters - 95% fewer than nnUNet (30.78M), 91% fewer than standard UNet (16.21M), and 85% fewer than a lightweight hybrid CNN-transformer network (Liu et al., 2024) (9.9M). Coupled with a 4.9× faster GPU inference time (0.904 ± 0.002 s vs. nnUNet's 4.416 ± 0.004 s), the design enables real-time deployment on resource-constrained devices while maintaining competitive segmentation accuracy. Code is available at: FFLUNet.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.compbiomed.2025.110460DOI Listing

Publication Analysis

Top Keywords

brain tumor
8
tumor segmentation
8
brain tumors
8
segmentation accuracy
8
segmentation
5
model
5
fflunet feature
4
feature fused
4
lightweight
4
fused lightweight
4

Similar Publications

Purpose: Patients diagnosed with high-grade gliomas (HGG) often experience substantial psychosocial dis-tress. However, due to neurological and neurocognitive deficits its assessment remains challenging, and needs remain unmet. We compared a novel face-to-face assessment during doctor-patient conversations with questionnaire-based screening.

View Article and Find Full Text PDF

Exploring Differentially Expressed Genes and Understanding the Underlying Mechanisms in Glioblastoma.

Biochem Genet

September 2025

Department of Medical Biology, Cerrahpasa Faculty of Medicine, Istanbul University Cerrahpasa, Kocamustafapasa, 34098, Istanbul, Turkey.

Glioblastoma is the most aggressive and malignant tumor of the central nervous system. Current treatment options, including surgical excision, radiotherapy, and chemotherapy, have Limited efficacy, with a median survival rate of approximately 15 months. To develop novel therapeutics, it is crucial to understand the underlying molecular mechanisms driving glioblastoma.

View Article and Find Full Text PDF

Rationale: Radial artery spasm (RAS) is a common complication during transradial cerebral angiography (TRA), but currently, the optimal prevention strategy is not well established. Papaverine has anti-vasospasm, sedative and analgesic effects. However, the efficacy of papaverine in preventing RAS during TRA remains unknown.

View Article and Find Full Text PDF

Wearable device-measured circadian rest-activity rhythm with mortality risk in patients with cancer.

BMJ Health Care Inform

September 2025

Center for Sleep and Circadian Medicine, The Affiliated Brain Hospital, Guangzhou Medical University, Guangzhou, Guangdong, China

Objectives: The objectives were to examine the associations between accelerometer-measured circadian rest-activity rhythm (CRAR), the most prominent circadian rhythm in humans and the risk of mortality from all-cause, cancer and cardiovascular disease (CVD) in patients with cancer.

Methods: 7456 cancer participants from the UK Biobank were included. All participants wore accelerometers from 2013 to 2015 and were followed up until 24 January 2024, with a median follow-up of 9.

View Article and Find Full Text PDF

Glioma is a malignant brain tumor in which the lncRNA ENSG00000232259 is significantly upregulated. Bioinformatics predictions suggest that it may encode the polypeptide ENSG00000232259-ORF, but the biological function and mechanisms of this polypeptide in glioma remain unclear. Gene expression and correlation analyses were conducted using the GEPIA database, combined with GetORF to predict the polypeptide-coding potential, and Western blot was employed to validate the expression of ENSG00000232259-ORF.

View Article and Find Full Text PDF